Literature DB >> 2530156

Immobilized anti-CD3 monoclonal antibodies induce accessory cell-independent lymphokine production, proliferation and helper activity in human T lymphocytes.

R A van Lier1, M Brouwer, V I Rebel, C J van Noesel, L A Aarden.   

Abstract

Monoclonal antibodies (mAb) directed against the human CD3 molecular complex are able, when immobilized on the plastic of microtitre wells, to induce accessory cell-independent T-cell proliferation. In this study, we show that the anti-CD3 mAb CLB-T3/3 induces strong T-cell stimulation that is proportional to the density of the immobilized antibody. T cells, optimally stimulated with plastic-immobilized CLB-T3/3, showed a five-fold higher proliferation compared to cells that were stimulated with soluble anti-CD3 in the presence of accessory cells. The difference in magnitude of proliferation was found to be correlated with the expression of the CD25 (TAC) antigen and the production of interleukin (IL)-2, but not with the number of high-avidity IL-2 receptors expressed on the surface of these differentially activated cells. In addition, immobilized CLB-T3/3 initiated the production of interferon-gamma (IFN-gamma), but not of IL-4, in purified T lymphocytes. Coated anti-CD3 mAb induced helper activity in T cells for IgM and IgG production by B lymphocytes. Whereas addition of IL-1 or IL-2 had only a moderate effect on T-cell proliferation induced by immobilized anti-CD3 mAb, helper activity was strongly enhanced in the presence of these factors. This T-cell activation system may prove useful for a standardized analysis of both activation requirements and immunoregulatory capacities of human T cells.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2530156      PMCID: PMC1385503     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  24 in total

1.  Simultaneous production of IL-2, IL-4, and IFN-gamma by activated human CD4+ and CD8+ T cell clones.

Authors:  X Paliard; R de Waal Malefijt; H Yssel; D Blanchard; I Chrétien; J Abrams; J de Vries; H Spits
Journal:  J Immunol       Date:  1988-08-01       Impact factor: 5.422

2.  T cell growth factor: parameters of production and a quantitative microassay for activity.

Authors:  S Gillis; M M Ferm; W Ou; K A Smith
Journal:  J Immunol       Date:  1978-06       Impact factor: 5.422

3.  Macrophage-independent activation of helper T cells. I. Production of Interleukin 2.

Authors:  J J Farrar; S B Mizel; J Fuller-Farrar; W L Farrar; M L Hilfiker
Journal:  J Immunol       Date:  1980-08       Impact factor: 5.422

Review 4.  Interleukin 1 and T cell activation.

Authors:  S B Mizel
Journal:  Immunol Rev       Date:  1982       Impact factor: 12.988

5.  Interleukin 2 regulates expression of its receptor and synthesis of gamma interferon by human T lymphocytes.

Authors:  G H Reem; N H Yeh
Journal:  Science       Date:  1984-07-27       Impact factor: 47.728

6.  Fc receptors for mouse IgG1 on human monocytes: polymorphism and role in antibody-induced T cell proliferation.

Authors:  W J Tax; F F Hermes; R W Willems; P J Capel; R A Koene
Journal:  J Immunol       Date:  1984-09       Impact factor: 5.422

7.  Triggering of the T3-Ti antigen-receptor complex results in clonal T-cell proliferation through an interleukin 2-dependent autocrine pathway.

Authors:  S C Meuer; R E Hussey; D A Cantrell; J C Hodgdon; S F Schlossman; K A Smith; E L Reinherz
Journal:  Proc Natl Acad Sci U S A       Date:  1984-03       Impact factor: 11.205

8.  Low and high affinity cellular receptors for interleukin 2. Implications for the level of Tac antigen.

Authors:  R J Robb; W C Greene; C M Rusk
Journal:  J Exp Med       Date:  1984-10-01       Impact factor: 14.307

9.  Mechanisms by which accessory cells contribute in growth of resting T lymphocytes initiated by OKT3 antibody.

Authors:  R Palacios
Journal:  Eur J Immunol       Date:  1985-07       Impact factor: 5.532

10.  Immunoglobulin production in human mixed lymphocyte cultures: implications for co-cultures of cells from patients and healthy donors.

Authors:  H C Rümke; F G Terpstra; B Huis; T A Out; W P Zeijlemaker
Journal:  J Immunol       Date:  1982-02       Impact factor: 5.422

View more
  22 in total

1.  Major histocompatibility complex class II- fetal skin dendritic cells are potent accessory cells of polyclonal T-cell responses.

Authors:  A Elbe-Bürger; A M Mommaas; E E Prieschl; E Fiebiger; T Baumruker; G Stingl
Journal:  Immunology       Date:  2000-10       Impact factor: 7.397

2.  CD6 synergistic co-stimulation promoting proinflammatory response is modulated without interfering with the activated leucocyte cell adhesion molecule interaction.

Authors:  P Nair; R Melarkode; D Rajkumar; E Montero
Journal:  Clin Exp Immunol       Date:  2010-08-19       Impact factor: 4.330

3.  LFA-1-dependent OKT3-driven T cell clusters in common variable immunodeficiency.

Authors:  W Rudnicka; N English; J Farrant; M E North; A E Bryant; A J Edwards; A Stackpoole; A D Webster; B M Balfour
Journal:  Clin Exp Immunol       Date:  1992-01       Impact factor: 4.330

4.  Adaptive immune responses during Shigella dysenteriae type 1 infection: an in vitro stimulation with 57 kDa major antigenic OMP in the presence of anti-CD3 antibody.

Authors:  Ashim Kumar Bagchi; Ajoy Kumar Sinha; Rushita Adhikari; Joydeep Mukherjee
Journal:  Mol Cell Biochem       Date:  2009-11-14       Impact factor: 3.396

5.  Antigen-presenting cell-derived signals determine expression levels of CD70 on primed T cells.

Authors:  S M Lens; P A Baars; B Hooibrink; M H van Oers; R A van Lier
Journal:  Immunology       Date:  1997-01       Impact factor: 7.397

6.  Impaired T-cell receptor activation in IL-1 receptor-associated kinase-4-deficient patients.

Authors:  Douglas R McDonald; Frederick Goldman; Oscar D Gomez-Duarte; Andrew C Issekutz; Dinakantha S Kumararatne; Rainer Doffinger; Raif S Geha
Journal:  J Allergy Clin Immunol       Date:  2010-08       Impact factor: 10.793

7.  Effector CD8+ T-cell Engraftment and Antitumor Immunity in Lymphodepleted Hosts Is IL7Rα Dependent.

Authors:  C Bryce Johnson; Brian P Riesenberg; Bennett R May; Stuart C Gilreath; Guangfu Li; Kevin F Staveley-O'Carroll; Elizabeth Garrett-Mayer; Shikhar Mehrotra; David J Cole; Mark P Rubinstein
Journal:  Cancer Immunol Res       Date:  2015-08-21       Impact factor: 11.151

8.  Poor induction of interleukin-2 receptor expression on CD8bright+ cells in whole blood cell cultures with CD3 mAb. Implications for immunotherapy with CD3 mAb.

Authors:  R A Janssen; A A Heijn; T H The; L de Leij
Journal:  Cancer Immunol Immunother       Date:  1994-01       Impact factor: 6.968

9.  Quantitative analysis of CD4+ T cell function in the course of human immunodeficiency virus infection. Gradual decline of both naive and memory alloreactive T cells.

Authors:  L Meyaard; S A Otto; B Hooibrink; F Miedema
Journal:  J Clin Invest       Date:  1994-11       Impact factor: 14.808

10.  Efficient expansion of tumor-infiltrating lymphocytes from solid tumors by stimulation with combined CD3 and CD28 monoclonal antibodies.

Authors:  M J Flens; W M Mulder; H Bril; M B von Blomberg van de Flier; R J Scheper; R A van Lier
Journal:  Cancer Immunol Immunother       Date:  1993-10       Impact factor: 6.968

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.